Cutera, Inc. (NASDAQ:CUTR) insider James A. Reinstein sold 7,175 shares of the company’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $45.35, for a total transaction of $325,386.25. Following the completion of the sale, the insider now directly owns 132,284 shares in the company, valued at $5,999,079.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Cutera, Inc. (NASDAQ:CUTR) traded down $1.10 on Friday, reaching $44.25. 222,700 shares of the company traded hands, compared to its average volume of 222,400. The firm has a market capitalization of $620.77, a PE ratio of 59.00, a PEG ratio of 1.35 and a beta of 0.52. Cutera, Inc. has a 1 year low of $17.48 and a 1 year high of $48.95.

Cutera (NASDAQ:CUTR) last released its earnings results on Tuesday, November 7th. The medical device company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.34. Cutera had a net margin of 7.99% and a return on equity of 18.73%. The firm had revenue of $38.17 million during the quarter, compared to analyst estimates of $34.82 million. During the same quarter in the previous year, the firm earned $0.12 earnings per share. The firm’s revenue for the quarter was up 26.1% compared to the same quarter last year. sell-side analysts expect that Cutera, Inc. will post 0.55 EPS for the current year.

Hedge funds have recently added to or reduced their stakes in the business. Parallel Advisors LLC bought a new stake in Cutera during the third quarter valued at $117,000. Legal & General Group Plc increased its stake in Cutera by 69.6% during the third quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock valued at $149,000 after purchasing an additional 1,477 shares during the last quarter. Greenwood Capital Associates LLC bought a new stake in Cutera during the third quarter valued at $210,000. Dynamic Technology Lab Private Ltd bought a new stake in Cutera during the third quarter valued at $264,000. Finally, Mackenzie Financial Corp bought a new stake in Cutera during the third quarter valued at $277,000. Hedge funds and other institutional investors own 87.64% of the company’s stock.

Several analysts recently issued reports on CUTR shares. Roth Capital upped their price target on shares of Cutera from $41.00 to $47.00 and gave the company a “buy” rating in a report on Tuesday, September 12th. Zacks Investment Research cut shares of Cutera from a “hold” rating to a “sell” rating in a report on Tuesday, December 26th. Maxim Group cut shares of Cutera from a “buy” rating to a “hold” rating in a report on Thursday, September 14th. Finally, BidaskClub raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Tuesday, December 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $37.33.

ILLEGAL ACTIVITY WARNING: “Cutera, Inc. (CUTR) Insider James A. Reinstein Sells 7,175 Shares” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.watchlistnews.com/cutera-inc-cutr-insider-james-a-reinstein-sells-7175-shares/1795784.html.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.